REFERENCES
1. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation 2021;143:e35-71.
2. Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561-632.
3. Avvedimento M, Tang GHL. Transcatheter aortic valve replacement (TAVR): recent updates. Prog Cardiovasc Dis 2021;69:73-83.
4. Fuchs A, Kofoed KF, Yoon SH, et al. Commissural alignment of bioprosthetic aortic valve and native aortic valve following surgical and transcatheter aortic valve replacement and its impact on valvular function and coronary filling. JACC Cardiovasc Interv 2018;11:1733-43.
5. Dumonteil N, Marcheix B, Lairez O, Laborde JC. Transcatheter aortic valve implantation for severe, non-calcified aortic regurgitation and narrow aortic root: description from a case report of a new approach to potentially avoid coronary artery obstruction. Catheter Cardiovasc Interv 2013;82:E124-7.
6. Tarantini G, Nai Fovino L, Scotti A, et al. Coronary access after transcatheter aortic valve replacement with commissural alignment: The ALIGN-ACCESS Study. Circ Cardiovasc Interv 2022;15:e011045.
7. Salmonsmith JA, Ducci A, Burriesci G. Does transcatheter aortic valve alignment matter? Open Heart 2019;6:e001132.
8. Khan JM, Rogers T, Weissman G, et al. Anatomical characteristics associated with hypoattenuated leaflet thickening in low-risk patients undergoing transcatheter aortic valve replacement. Cardiovasc Revasc Med 2021;27:1-6.
9. Tarantini G, Nai Fovino L, Le Prince P, et al. Coronary access and percutaneous coronary intervention up to 3 years after transcatheter aortic valve implantation with a balloon-expandable valve. Circ Cardiovasc Interv 2020;13:e008972.
10. Tang GHL, Zaid S, Ahmad H, Undemir C, Lansman SL. transcatheter valve neo-commissural overlap with coronary orifices after transcatheter aortic valve replacement. Circ Cardiovasc Interv 2018;11:e007263.
11. Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the re-access study. JACC Cardiovasc Interv 2020;13:2542-55.
12. Ochiai T, Chakravarty T, Yoon SH, et al. Coronary access after TAVR. JACC Cardiovasc Interv 2020;13:693-705.
13. Yudi MB, Sharma SK, Tang GHL, Kini A. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol 2018;71:1360-78.
14. Tarantini G, Dvir D, Tang GHL. Transcatheter aortic valve implantation in degenerated surgical aortic valves. EuroIntervention 2021;17:709-19.
15. Tang GHL, Zaid S. Coronary re-access after redo TAVI: a proposed classification to simplify evaluation. EuroIntervention 2020;16:e960-2.
16. Ochiai T, Oakley L, Sekhon N, et al. Risk of coronary obstruction due to sinus sequestration in redo transcatheter aortic valve replacement. JACC Cardiovasc Interv 2020;13:2617-27.
17. Tarantini G, Nai Fovino L. Coronary access and TAVR-in-TAVR: don't put off until tomorrow what you can do today. JACC Cardiovasc Interv 2020;13:2539-41.
18. Khan JM, Babaliaros VC, Greenbaum AB, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: results from the multicenter international BASILICA registry. JACC Cardiovasc Interv 2021;14:941-8.
19. Tang GHL, Zaid S, Gupta E, et al. Impact of initial evolut transcatheter aortic valve replacement deployment orientation on final valve orientation and coronary reaccess. Circ Cardiovasc Interv 2019;12:e008044.
20. Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR): impact on final valve orientation and coronary artery overlap. JACC Cardiovasc Interv 2020;13:1030-42.
21. Tang GHL, Sengupta A, Alexis SL, et al. Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy. Catheter Cardiovasc Interv 2022;99:924-31.
22. Bieliauskas G, Wong I, Bajoras V, et al. Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves. JACC Cardiovasc Interv 2021;14:2097-108.
23. Fabris E, Vitrella G, Rakar S, Perkan A, Bedogni F, Sinagra G. Hat-marker orientation to minimize neo-commissural overlap with coronaries during corevalve evolut TAVR. JACC Cardiovasc Interv 2020;13:782-3.
24. Takamatsu M, Fuku Y, Ohya M, Shimamoto T, Komiya T, Kadota K. Lateral approach for modifying hat-marker orientation to minimize neo-commissural overlap during transcatheter aortic valve replacement. JACC Cardiovasc Interv 2020;13:e199-201.
25. Kitamura M, Wilde J, Dumpies O, et al. Patient-specific neocommissural alignment of the evolut valve: a pilot study in transcatheter aortic Valve-in-Valve replacement. JACC Cardiovasc Interv 2021;14:934-6.
26. Spilias N, Sabbak N, Harb SC, et al. A novel method of assessing commissural alignment for the SAPIEN 3 transcatheter aortic valve. JACC Cardiovasc Interv 2021;14:1269-72.
27. Moriyama N, Shishido K, Yokota S, et al. Coronary access after TAVR with a cylindrical shaped valve: Learning from LOTUS. Cardiovasc Revasc Med ;2021:S1553-8389(21)00273.
28. Tang GHL, Zaid S. Commissural alignment using cusp-overlap view in self-expanding TAVR: a step closer to achieving surgical-like orientation? JACC Cardiovasc Interv 2021;14:2109-11.
